'Something going on?' Doctor raises alarm as key hair-loss drug vanishes from Trump chart

President Donald Trump's latest medical results have something unsettling buried in them, Dr. Jonathan Reiner posted to X on Thursday — and what it means exactly is obfuscated by a conspicuous absence in his medication records.

At the core of the issue, wrote Dan Diamond for The Washington Post, is the drug finasteride, a common treatment for hair loss among men. Although three of Trump's previous doctors have said he uses it, "the drug has not appeared on Trump’s medical reports since he returned to office last year, including a report released Friday night that mentioned three other medications."

For one thing, said Diamond, the lack of transparency about why Trump stopped using the medication only adds to questions about what the almost 80-year-old president might be hiding.

But more specifically, Reiner pointed out in response to the article that it raises questions about another result to be found in Trump's blood work.

Finasteride has a secondary use beyond treating hair loss; it is also used to prevent prostate cancer, as its use reduces levels of prostate-specific antigen (PSA) in the blood. "Trump’s PSA levels in 2016 were noticeably low, according to Bornstein’s summary, sparking questions from medical experts," noted Diamond — and they are still relatively low, but they have increased significantly from where they were before.

What that means, Reiner said, is impossible to say because of the lack of transparency.

"Since WH won’t disclose if he’s taking finasteride we don’t know why his PSA has risen 10x from last yr’s 0.1 to 1.0 now," wrote Reiner. "Did he stop taking the drug, or is he still taking it and now there’s something going on with his prostate? That’s why it’s important."

Prostate cancer is a common ailment in older men, many of whom spend their final years unaware they have it and die while it is still in the early stages. Former President Joe Biden was diagnosed with an aggressive form of the disease last year.